ENT-03: A Novel Compound for Obesity and Type 2 Diabetes

ENT-03 is a centrally-acting endogenous steroidal molecule (spermine-bile acid) that regulates whole-body responsiveness to insulin, energy homeostasis and body weight.

  • Potent inhibitor of PTP1, an established Obesity and Type 2 Diabetes target

  • Rapidly normalizes glucose and induces weight loss

  • Has additive effects with GLP-1 agonists

  • Subcutaneously administered

  • Preserves lean muscle loss and has sustained effect after therapy cessation

Over 36 million Americans now live with diabetes and the numbers continue to increase. ENT-03 can help.

Have questions?